Adagio Medical received a formal notice from Nasdaq on June 12, 2026, regarding failure to maintain a minimum bid price of $1.00 per share. The company has 180 calendar days, until December 9, 2026, to regain compliance. Compliance is achieved if the stock price closes at or above $1.00 for at least ten consecutive business days during the grace period. The company's common stock continues to trade on the Nasdaq Capital Market during this period.